Talking Rheumatology Research

British Society for Rheumatology
  • 5.0 (1)
  • MEDICINE
  • UPDATED WEEKLY

Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.

  1. 08/13/2025

    Ep 51. Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial

    In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice!   Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    8 min

  2. 06/12/2025

    Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica

    How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica? In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study.  Further reading: Read Steven's full study in Rheumatology Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    9 min

  3. 05/08/2025

    Ep 49. Improving time to diagnosis in axial spondyloarthritis

    How can we improve time from symptom onset to axSpA diagnosis? In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated referral and education system. They discuss the importance of a multi-pronged approach to education, as well as how clinicians might start improving time to axSpA diagnosis in their own settings.  Further reading:  Read Antoni's full article in Rheumatology Advances in PracticeFind out more about the Act on Axial SpA campaignAccess the axSpA symptom checker Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    11 min

  4. 10/24/2024

    Ep 48. Deciphering difficult-to-treat psoriatic arthritis

    Should there be distinct definitions for difficult-to-treat and complex-to-manage psoriatic arthritis? In this episode of Talking Rheumatology Research, Dr Fabian Proft and Dr Andre Ribeiro join Dr Ai Lyn Tan to discuss their work to define difficult-to-treat psoriatic arthritis, as part of GRAPPA's wider D2T-PsA project.  Find out more:  Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals Find out more about GRAPPA and its work Keywords: psoriatic arthritis, PSA, difficult-to-treat, D2T, complex-to-manage, C2M, GRAPPA, rheumatology.  Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    18 min

  5. 08/25/2024

    Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

    Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients.  Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition. You can read this article [https://doi.org/10.1093/rheumatology/kead604] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    11 min

  6. 07/11/2024

    Ep 46. Patient involvement in Rheumatology research

    Peter Boyd and Ingrid de Groot join Dr. Latika Gupta to explore the value of patient involvement in Rheumatology research. Reflecting on their lived experience, Peter and Ingrid discuss their proudest moments, and identify areas in the patient and physician partnership that they hope to improve in the future. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    21 min

  7. 06/13/2024

    Ep 45. Community awareness of childhood arthritis in the UK

    Recorded at #BSR24, Richard P Beesley joins Dr Ai Lyn Tan to discuss his recent article, which measured the level of community awareness in the UK that children and young people can develop arthritis. Listen now to hear about what you can do to help raise awareness of childhood arthritis, and why this is so important. You can read this article [https://doi.org/10.1093/rap/rkad099] in Rheumatology Advances in Practice. Keywords: Juvenile idiopathic arthritis, arthritis, awareness, communication Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    10 min

  8. 05/23/2024

    Ep 44. Neuropsychiatric symptoms in systemic autoimmune rheumatic diseases

    In this fascinating episode recorded at #BSR24, Dr Melanie Sloan joins Prof Ernest Choy to discuss the latest results from the INSPIRE study, which seeks to understand neuropsychiatric symptom prevalence and impact in people with systemic autoimmune rheumatic diseases (SARDs).  Dr Melanie Sloan is a researcher in the Department of Public Health and Primary Care at the University of Cambridge. Her research focuses on improving patient-clinician relationships, as well as trialling interventions for patients with SARDs.   Want to find out more about Melanie’s research? Here’s your further reading list:  Prevalence and identification of neuropsychiatric symptoms in SARDs Neuropsychiatric symptoms in lupusAttribution of neuropsychiatric symptoms and prioritisation of evidence in lupusProdromal neuropsychiatric symptoms in lupus Keywords: autoimmune diseases, lupus, rheumatology, nightmares, daymares, mental health, psychosis, communication.  Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    13 min
See All (51)

About

Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.

Information

  • Creator
    British Society for Rheumatology
  • Years Active
    2022 - 2025
  • Episodes
    51
  • Rating
    Clean
  • Copyright
    © 2025 Talking Rheumatology Research
  • Show Website
    Talking Rheumatology Research